Table 1.
Descriptive parameters of two CASES.
| Characteristics | Patient 1 | Patient 2 |
|---|---|---|
| Sex | Male | Male |
| Age (years) | 40 yrs | 75 yrs |
| Previous STIs | None | None |
| Recent sexual exposure | No | No |
| Systemic symptoms | Fever, headache | none |
| Days from systemic symptoms to appearance of lesion |
1 | NA |
| Localization of skin lesions | Genital, thorax, scalp, trunk, abdomen, perineal area | Back, legs, |
| foot sole, hand, scalp, trunk, abdomen | ||
| Evolution of lesions | Asynchronous | Asynchronous |
| Laboratory Findings | ||
| WBC (cell/mmc) | 6090 | 7050 |
| Monocytes | 480 | 670 |
| Lymphocytes | 1770 | 3080 |
| AST/ALT (<40 UI/mL) | 20/54 | 34/48 |
| LDH (250 UI/mL) | 235 | 227 |
| INR | 1,31 | 1,24 |
| CRP | 0,2 | 0 |
| IL2R(223–710 IU/mL) | 894,000 | 737,000 |
| IL6 (0–5 pg/mL) | 4,5 | n.d * |
| VZV IgM/IGG | −/+ | +/− |
| HSV1/HSV2-DNA | −/− | −/− |
| SARS-CoV-2 IgG | + | + |
| SARS-CoV-2 RNA | − | − |
| MonkeyPox DNA | + | − |
Table shows major clinical and laboratory features of both patients. * means “not determined” result of evaluated laboratory parameter.